Related Experiment Videos
Prolonged course of familial hemophagocytic lymphohistiocytosis
Orna Steinberg1, Joanne Yacobovich, Orly Dgany
1Department of Pediatrics A, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel.
Insights
Familial hemophagocytic lymphohistiocytosis (HLH) is a rare, fatal condition. A 10-year-old boy with a PRF1 gene mutation achieved cure through the HLH-2004 protocol and bone marrow transplant, highlighting disease heterogeneity.
Area of Science:
- Pediatric Hematology
- Immunology
- Genetics
Background:
- Familial hemophagocytic lymphohistiocytosis (FHL) is a rare, life-threatening genetic disorder.
- Typically diagnosed within the first two years of life, FHL presents with uncontrolled immune activation.
- Untreated FHL leads to rapid fatality due to cytokine storm and organ damage.
Observation:
- A 10-year-old boy presented with a prolonged 9-year history of fever and hepatosplenomegaly.
- The patient was diagnosed with FHL type 2, confirmed by homozygosity for a PRF1 gene mutation.
- This presentation is atypical, occurring significantly later than the usual pediatric diagnosis window.
Findings:
- The patient received treatment according to the HLH-2004 protocol.
- Successful allogeneic bone marrow transplantation was performed.
- The patient achieved a cure, indicating the efficacy of the treatment protocol in this late-presenting case.
Implications:
- This case underscores the significant clinical heterogeneity of FHL.
- Late-onset FHL is possible and requires consideration in differential diagnoses.
- Aggressive treatment, including bone marrow transplantation, can be curative even in atypical presentations.
Abstract:
Familial hemophagocytic lymphohistiocytosis is usually diagnosed in the first 2 years of life and, if untreated, is rapidly fatal. We describe a 10-year-old boy with a 9-year history of prolonged fever and progressive hepatosplenomegaly who was diagnosed as having hemophagocytic lymphohistiocytosis 2, being homozygote to a previously described mutation in the PRF1 gene, and cured by the HLH-2004 protocol and allogenic bone marrow transplantation. This unique case emphasizes the heterogeneity of this disease and the diversity of its clinical presentations.
Related Concept Videos
Huntington Disease l: Introduction
Lysosomal Hydrolases
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cytomegalovirus Disease
Hepatitis